[HTML][HTML] Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case–control study
EV Arkema, BL Goldstein, W Robinson… - Arthritis research & …, 2013 - Springer
Introduction The aim of this study was to characterize anti-citrullinated peptide antibody
(ACPA) serostatus in pre-clinical rheumatoid arthritis (RA) with and without Human …
(ACPA) serostatus in pre-clinical rheumatoid arthritis (RA) with and without Human …
[HTML][HTML] Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study
W Qi, J Zhao, C Huang, N Jiang, J Li, C Wu… - Arthritis Research & …, 2022 - Springer
Background Antiphospholipid syndrome (APS) is an autoimmune disease characterized by
persistent antiphospholipid antibodies (aPLs) positivity with a wide manifestation spectrum …
persistent antiphospholipid antibodies (aPLs) positivity with a wide manifestation spectrum …
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
MG Tektonidou, K Laskari… - Arthritis Care & …, 2009 - Wiley Online Library
Objective Antiphospholipid antibodies (aPL), namely anticardiolipin antibodies (aCL) and
lupus anticoagulant (LAC), have been associated with an increased risk of thrombosis in …
lupus anticoagulant (LAC), have been associated with an increased risk of thrombosis in …
[PDF][PDF] Immunoglobulin G1 antibodies against phosphorylcholine are associated with protection in systemic lupus erythematosus and atherosclerosis: Potential …
D Thiagarajan, R Fiskesund, A Frostegård… - ACR open …, 2020 - Wiley Online Library
Objective Immunoglobulin M antibodies against phosphorylcholine (anti‐PC s) may be
protective in atherosclerosis, cardiovascular disease (CVD), and systemic lupus …
protective in atherosclerosis, cardiovascular disease (CVD), and systemic lupus …
[HTML][HTML] “Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort
T Liu, J Gu, L Wan, Q Hu, J Teng, H Liu… - Arthritis research & …, 2020 - Springer
Background Despite expansion in the 2006 Sydney antiphospholipid syndrome (APS)
classification criteria to include IgG/IgM anti-β2-glycoprotein (aβ2GPI) antibodies in addition …
classification criteria to include IgG/IgM anti-β2-glycoprotein (aβ2GPI) antibodies in addition …
Association between antiphospholipid antibodies and arterial thrombosis in patients with rheumatoid arthritis
KJ Kim, IW Baek, KS Park, WU Kim, CS Cho - Lupus, 2017 - journals.sagepub.com
Objectives Antiphospholipid antibodies (aPL) are present in a proportion of patients with
rheumatoid arthritis but their clinical significance remains unclear. We investigated the …
rheumatoid arthritis but their clinical significance remains unclear. We investigated the …
Characteristics of patients with antiphospholipid antibody positivity in the APS ACTION international clinical database and repository
Objective To describe the baseline characteristics of patients with positivity for
antiphospholipid antibodies (aPLs) who were enrolled in an international registry, the …
antiphospholipid antibodies (aPLs) who were enrolled in an international registry, the …
[引用][C] Antiphospholipid antibody profiling: association with the clinical phenotype of antiphospholipid syndrome? Comment on the article by Otomo et al
D Roggenbuck, K Egerer, E Feist… - Arthritis & …, 2012 - Wiley Online Library
We read with great interest the article by Otomo et al, which provided a formula for improved
risk assessment in patients with APS by determining the aPL-S (1). Their addition of assays …
risk assessment in patients with APS by determining the aPL-S (1). Their addition of assays …
Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid …
S Ajeganova, ULF de Faire, T Jogestrand… - The Journal of …, 2012 - jrheum.org
Objective. Although an enhanced risk of cardiovascular disease (CVD) in persons with
rheumatoid arthritis (RA) is well established, the mechanisms behind it remain unclear. We …
rheumatoid arthritis (RA) is well established, the mechanisms behind it remain unclear. We …
[HTML][HTML] Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic …
D Roggenbuck, MO Borghi, V Somma, T Büttner… - Arthritis research & …, 2016 - Springer
Background Antiphospholipid antibodies (aPL) can be detected in asymptomatic carriers
and infectious patients. The aim was to investigate whether a novel line immunoassay (LIA) …
and infectious patients. The aim was to investigate whether a novel line immunoassay (LIA) …